To assess changes in the mortality gap between individuals diagnosed with bipolar disorder or schizophrenia and the general population over time.
Conducted a population-based cohort study in the United Kingdom spanning from 2000 to 2014.
Tracked and compared mortality outcomes between individuals with schizophrenia or bipolar disorder and the general population.
Demonstrated that the mortality disparity between individuals diagnosed with bipolar disorder or schizophrenia and the general population widened between 2000 and 2014.
Abstract
The mortality gap between individuals with bipolar disorder and schizophrenia, and the general population is widening.